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Abstract. 
 
We report the isolation of adherent, clono-
genic, ﬁbroblast-like cells with osteogenic and adipogenic
potential from the blood of four mammalian species.
These cells phenotypically resemble but are distinguish-
able from skeletal stem cells found in bone marrow
(stromal stem cells, “mesenchymal stem cells”). The os-
teogenic potential of the blood-borne cells was proven
by an in vivo transplantation assay in which either poly-
clonal or single colony–derived strains were trans-
planted into the subcutis of immunocompromised mice,
and the donor origin of the fully differentiated bone
cells was proven using species-speciﬁc probes. This is
the ﬁrst deﬁnitive proof of the existence of circulating
skeletal stem cells in mammals.
Key words: blood cells • tissue culture • adherent col-
onies • transplantation • osteogenesis
 
Introduction
 
The post-natal bone marrow of mammals harbors two pop-
ulations of stem/progenitor cells that are thought of as part
of separate lineages and exhibit distinct fundamental biolog-
ical properties: (a) hematopoietic stem cells, which are non-
adherent and circulating, and (b) stromal stem cells, which
are adherent and fibroblastic in habit, and noncirculating
(Friedenstein et al., 1968; Bianco and Riminucci, 1998).
Stromal stem cells can give rise to all major skeletal tissues,
such as cartilage, bone, myelosupportive stroma, and associ-
ated adipocytes, and fibrous connective tissue (Friedenstein
et al., 1966, 1968; Owen, 1988). Throughout development,
these particular tissues are thought to be formed entirely by
extravascular mesodermal progenitors that associate with
developing skeletal rudiments via migratory processes that
do not rely upon their ability to circulate in blood (Bianco
and Riminucci, 1998). Other solid-phase mesodermal tissues
such as skeletal muscle also fall into the same general cate-
gory (Cossu et al., 1996; Bianco and Cossu, 1999).
Recent data have shown that both muscle and skeletal
cells of donor origin differentiate within muscle and bone
when marrow-derived cell populations are infused into the
systemic circulation under some experimental conditions
(Ferrari et al., 1998; Hou et al., 1999). These data provide
evidence for at least some degree of systemic transplant-
ability of progenitors of solid-phase mesodermal tissues.
Complete reconstitution of the hematopoietic system after
the systemic infusion of progenitor/stem cells illustrates the
natural properties of the hematopoietic stem cell; hemato-
poietic stem cells are capable of negotiating the circulation
and homing to the bone marrow in normal physiology.
Whether any physiological event relevant to extravascular
mesodermal tissues calls for the existence of a naturally
circulating progenitor cell remains to be determined. Criti-
cal to addressing this question would be the demonstration
of circulating progenitors for solid-phase mesodermal tis-
sues in the intact organism.
In this study, we isolated adherent and clonogenic cells
from whole blood of adult animals of four different species
(mouse, rabbit, guinea pig, and human). We demonstrated
that some polyclonal strains and several single colony–
derived strains formed bone upon in vivo transplantation,
the gold standard assay of osteogenic potential. Further-
more, they were capable of forming adipocytes in vitro.
These studies prove for the first time that some circulating
cells that can form adherent colonies on plastic are compe-
tent to form genuine bone tissue in vivo, and establish for the
first time the existence of circulating osteogenic stem cells.
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Materials and Methods
 
Blood Collection
 
All procedures were performed in accordance to specifications of institution-
ally approved animal protocols. Blood from mice (BALB/cj and Swiss NIH-
SW-CR), rabbits (New Zealand), and guinea pigs (Hartley) was collected by
cardiac puncture in syringes containing sodium heparin (Fisher Scientific) at
a final concentration of 100 U/ml. Human venous blood was collected from
healthy volunteers under National Institutes of Health (NIH)-approved pro-
tocols, and was mixed with sodium heparin at a final concentration of 100
U/ml. Alternatively, human buffy coat concentrates with citrate (CDPA-1),
byproducts of blood donated for transfusion, were also used. Blood was har-
vested from donors of varying ages as indicated in Table I.
 
Cell Culture
 
Whole blood from mice, rabbits, and guinea pigs, and whole blood, total
buffy coat cells, and mononuclear buffy coat cells from humans, were
plated in a range of cell densities (Table I). In most instances, standard
plastic culture vessels were used (Becton Dickinson). Some human sam-
ples were plated in either fibronectin-coated flasks (Becton Dickinson) or
collagen type I–coated dishes (Flexcell International); however, this was
not found to increase colony formation. Culture media of several compo-
sitions were used based on 
 
 
 
MEM (Life Technologies), 2 mM 
 
L
 
-gluta-
mine, 100 U/ml penicillin, 100 
 
 
 
g/ml streptomycin sulfate (Biofluids), with
20% serum (FBS; Equitech-Bio) or human serum blood type AB (Pel-
Freez), or a combination of the two), with or without 10
 
 
 
8
 
 M dexametha-
sone (Sigma-Aldrich) and 10
 
 
 
4
 
 M ascorbic acid phosphate (Wako), or 100
ng/ml of mouse or human leukemia inhibitory factor (Life Technologies,
R&D Systems). However, medium composition did not influence the
number of colonies formed within an experiment, and consequently the
data were pooled. Cells were cultured at 37
 
 
 
C in an atmosphere of 100%
humidity and 5% CO
 
2
 
. Complete medium replacement was performed 1 d
after plating and twice a week thereafter. Colonies consisting of 50 or
more cells were counted between 10 and 41 d, depending on the animal
species. 1–3 d later, the cells were released by trypsin-EDTA (Life Tech-
nologies). Colonies were detached either simultaneously to generate poly-
clonal strains (guinea pig), or individually using cloning cylinders to gen-
erate single colony–derived strains (mouse, rabbit, and human). Cells
were then plated at 0.1–0.2 
 
  
 
10
 
5
 
 cells/cm
 
2
 
. Subsequent passages were per-
formed when cells were approaching confluence. Adipogenic conversion
of passaged cells was determined by using medium with 20% rabbit serum
(Life Technologies), as previously described (Diascro et al., 1998). 
 
Cultures of Bone Marrow Stromal 
Cells and Skin Fibroblasts
 
Long bones of mice, rabbits, and guinea pigs were obtained according to
specifications of an approved animal protocol. Fragments of human bone
were obtained from patients undergoing corrective surgery in accordance
with NIH regulations governing the use of human subjects in research.
Single cell suspensions of bone marrow were prepared and cultures of
bone marrow stromal cells were established as described previously (Kuz-
netsov and Gehron Robey, 1996). Murine skin fibroblasts and human
foreskin fibroblasts were cultured as described previously (Kuznetsov and
Gehron Robey, 1996; Krebsbach et al., 1997; Satomura et al., 2000).
 
Phenotypic Characterization
 
Polycolonal and single colony–derived strains of blood-derived adherent
cells and marrow stromal cells from each species were plated in eight-
chamber slides (VWR Scientific) at 2 
 
  
 
10
 
4
 
 cells/cm
 
2
 
 for immunohis-
tochemical analysis with a panel of antibodies, as described previously
(Gronthos et al., 2000) (see Table II). Bound antibody was localized using
either peroxidase-conjugated Ig (ABC kit; Vector Laboratories) or FITC-
conjugated Ig (Wako), serotyped according to the species of primary anti-
body. In other cases, histochemical staining was performed by standard
protocols using diagnostic kits for 
 
 
 
-naphthyl acetate esterase, acid phos-
phatase, alkaline phosphatase (kits 91-A, 387-A, and 86-C, respectively;
Sigma-Aldrich), and Oil Red O for visualization of lipid accumulation.
Slides were viewed using an Axioplan 2 (Carl Zeiss, Inc.), and images
were acquired uisng a DMC-1 digital camera (Polaroid Corp.) and Photo-
shop 5.0 software (Adobe Systems Inc.).
 
Table I. Donor and Cell Culture Characteristics in the Determination of Colony-forming Efficiency of Blood-derived Adherent Cells
 
Aminal species
No. of 
donors Age range
Plating density
 
 
 
 10
 
5
 
/cm
 
2
 
Colony-forming
efficiency/10
 
6
 
cells
Range between
donors
No. of polygonal/
fibroblast-like
colonies
Percent
polygonal
No. of
osteogenic
clones/clones
transplanted
 
Mouse 37 3 wk–2 yr 0.2–1.4 0.93 0–3.8 5/33 13 1/8
Rabbit 5 9–10 mo 1.4–3.2 0.18 0–0.58 6/41 13 3/19
Guinea pig 5 5–8 mo 0.5–2.2 2.7 1.1–3.9 15/319 5 2/4*
Human 10 22–60 yr 1–37.3 Rare 0–0.025 0/2 0 1/2
 
*Guinea pig cultures were derived as polyclonal rather than single colony–derived strains.
Figure 1. Identification of skeletal stem cells in peripheral
blood. Blood obtained from mice, rabbits, guinea pigs, and hu-
mans was plated in vitro. In all four species, adherent clonogenic
colonies were formed. After ex vivo expansion, they were at-
tached to ceramic particles and transplanted in the subcutis of
immunocompromised mice. After 8 wk, the transplants were ex-
amined for bone formation. The donor origin of bone in guinea
pig and human transplants was determined using species-specific
repetitive DNA sequences. 
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Figure 3.  Representative immunophenotype of blood-derived
adherent cells. Although two morphologically distinct types of
cells were detected in three of the four animal species, their immu-
nophenotype was identical, and this did not vary significantly from
one species to another. Their similarity to marrow stromal cells is
demonstrated by their expression of (A) type I collagen, (B) fi-
bronectin, (C) osteonectin, and (D)  -smooth muscle actin, and
variable expression of (E) osteopontin and (F) bone sialoprotein.
 
In Vivo Transplantation Assay
 
An in vivo transplantation assay was employed to study the osteogenic po-
tential of the blood-derived adherent cells (see Fig. 1) along with marrow
stromal cells (as a positive control) and murine and human fibroblasts (as
negative controls), as previously reported (Krebsbach et al., 1997). Cells
were trypsinized, pelleted, resuspended in 1 ml of culture medium, and
1.5–3.0 
 
 
 
 10
 
6
 
 cells were mixed with 40 mg of hydroxyapatite/tricalcium
phosphate ceramic powder (particle size 0.5–1.0 mm, generously provided
by Zimmer, Inc.). After a 90-min incubation at 37
 
 
 
C with rotation, the par-
ticles with attached cells were collected by a brief centrifugation. A sec-
ondary matrix was formed by mixing 15 
 
 
 
l of mouse fibrinogen (3.2 mg/ml
in PBS) and 15 
 
 
 
l of mouse thrombin (25 U/ml in 2% CaCl
 
2
 
; Sigma-
Aldrich) such that a solid fibrin gel was formed. The transplants were
placed in subcutaneous pockets in the backs of 8–15-wk-old immunocom-
promised female mice (bg-nu/nu-xid; Harlan Sprague Dawley). The trans-
plants were recovered 8 wk later, fixed in 4% phosphate-buffered formalin
(Sigma-Aldrich), decalcified in 10% EDTA, pH.8.0 (Quality Biological,
Inc.), and embedded in paraffin or glycol methacrylate. 5- or 7-
 
 
 
m sections
were prepared from each block and either stained with hematoxylin and
eosin (paraffin sections) or Goldner’s modified trichrome stain (glycol
methacrylate), or used for in situ hybridization (paraffin).
 
In Situ Hybridization for Species-specific 
Repetitive DNA Sequences
 
In situ hybridization for species-specific DNA sequences was used to de-
termine the origin of bone formed in the transplants of guinea pig– and
human blood–derived adherent cells. A 3,878-bp long guinea pig repeti-
tive DNA sequence (GenBank accession no. AF318129; provided by
Prof. J. Spencer, Queen’s University, Kingston, Ontario, Canada, and Dr.
J. Fredenburgh, Hamilton Civic Hospitals Research Center, Hamilton,
Ontario, Canada) was evaluated, and revealed no homology with either
mouse or human genomic DNA in a BLAST search. Several sets of prim-
ers were created, and one was chosen based on its performance in PCR
and, subsequently, in in situ hybridization. This set was sense: 5
 
 
 
-CTC-
CTGTCCTGCATCCACT-3
 
  
 
and antisense: 5
 
 
 
-GGATATGAGAGA-
CAGTGGTG-3
 
 
 
. Two consecutive PCR amplifications were used to gen-
erate digoxigenin-labeled guinea pig–specific probes. In the first PCR,
Platinum Taq DNA Polymerase kit (Life Technologies) was used with 1
 
 
 
g of specific primers and 1 
 
 
 
g of either guinea pig or mouse genomic
DNA. Using this primer set, one intense band (345 bp) was formed with
guinea pig but not mouse genomic DNA. The band was excised and puri-
fied using the Qiaex II Gel Extraction Kit (QIAGEN) according to the
manufacturer’s recommendations. The product was reamplified in the sec-
ond PCR using the same Platinum Taq DNA Polymerase kit except that
0.1 mM dNTP was substituted with 0.1 mM dATP, 0.1 mM dCTP, 0.1 mM
dGTP, 0.065 mM dTTP (PerkinElmer), and 0.035 mM digoxigenin-11-
dUTP (Boehringer). The digoxigenin-labeled probe specific for human
repetitive 
 
alu
 
 sequence was created using primers and PCR conditions
reported previously (Kuznetsov et al., 1997). The guinea pig– and human-
specific digoxigenin-labeled probes were used for in situ hybridization
according to a technique specifically modified for decalcified sections of
hydroxyapatite-containing transplants (Kuznetsov et al., 1997). Digoxige-
nin-labeled DNA was detected by immunohistochemistry using antidigox-
igenin alkaline phosphatase-conjugated Fab fragments (Boehringer).
 
Results and Discussion
 
Clonogenic adherent cells were observed in cultures of pe-
ripheral blood from all species investigated, albeit with sig-
nificant variation in colony forming efficiency (number of
colonies per 10
 
6
 
 nucleated cells) across animal species, and
from one individual donor to another (Table I). In all spe-
cies except human (in which a total of two colonies were
obtained), two distinct types of cell morphology were ob-
served. The majority of the colonies were composed of
cells with fibroblastic morphology, but a number of colo-
nies consisted of cells that exhibited a distinctive polygonal
shape (Fig. 2). However, upon characterization of cloned
strains of both types with a broad panel of markers, the
pattern was virtually identical (Table II and Fig. 3). This
was noted for the lack of expression of hematopoietic
(CD45, CD14) and endothelial (endoglin, CD34, Factor
VIII–related antigen, Muc-18, PAL-E, EN4) markers,
variable expression of osteogenic makers (osteopontin and
bone sialoprotein), and the consistent expression of col-
Figure 2. Morphological features of blood-derived adherent
clonogenic cells. The majority of clones that developed from all
animal species, including the two human colonies (A and B) con-
sisted of cells with a fibroblastic morphology. However, between
5 and 13% of the colonies, depending on the species, had a dis-
tinctly polygonal morphology in mouse (C), rabbit (D), and
guinea pig (not shown). 
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lagen types I and III, fibronectin, osteonectin, 
 
 
 
-smooth
muscle actin, CD44, VCAM-1, and the 
 
 
 
1 integrin subunit.
The phenotypic profile of blood-borne adherent cells over-
all was nearly identical between species (rabbit, guinea pig,
 
Table II. Phenotypic Characterization of Multicolony-derived Strains of Human Marrow Stromal Cells and Guinea Pig
Blood-derived Adherent Cells, and of Single Colony–derived Strains of Human and Rabbit Blood-derived Adherent Cells
 
Marker
Rabbit
polygonal 
non-osteogenic
Rabbit
fibroblast-like
osteogenic
Guinea pig
osteogenic
Human
fibroblast-like
non-osteogenic
Human
fibroblast-like
osteogenic
Human marrow
stromal cells
 
Fibroblastic
Col I (LF41)*
 
                
 
Col III (LF71)*
 
                
 
Fibronectin (rabbit; ICN Biomedicals)
 
     
 
Fibronectin (guinea pig, MsGP13; Serotec)
 
  
 
CD44 (H9H11)
 
‡
 
        
 
 
1 integrin subunit (MAB1959, 
Chemicon)
 
          
 
Osteogenic
ON (BON-1)*
 
                    
 
OPN (LF123)*
 
                     
 
BSP (LF83)*
 
                
 
OC (LF32)*
 
           
 
Adipocytic
CEBP
 
 
 
 (Santa Cruz Biotechnology, Inc.)
 
           
 
PPAR
 
 
 
2 (Santa Cruz Biotechnology, Inc.)
 
      
 
Endothelial
CD34 (Dako)
 
   
 
Muc-18
 
§
 
   
 
Factor VIII (Dako)
 
   
 
Endoglin
 
 
 
   
 
PAL-E (rabbit; Accurat Chemical 
Scientific)
 
  
 
EN4 (guinea pig; Accurat Chemical 
Scientific)
 
 
 
Marrow stromal cells
Stro-1
 
¶
 
       
 
CD106 (VCAM-1) (human, MCA907; 
Serotec)
 
       
 
Smooth muscle
 
 
 
-Smooth muscle actin (1A4; Dako)
 
                    
 
Smooth muscle (rabbit and guinea pig,
ACL-10002; Accurat Chemical Scientific)
 
          
 
Skeletal muscle
MyoD (M318; Dako)
 
   
 
Monocyte/macrophage
CD14 (human, TUK4; Dako)
 
   
 
RAM11 (rabbit; Dako)
 
  
 
MR-1 (guinea pig; Serotec)
 
 
 
Leukocyte
CD45 (human, 2B11/PD7-26; Dako)
 
   
 
CD45 (rabbit, L12/201; Serotec)
 
  
 
CD45 (guinea pig, 1H-1; Serotec)
 
 
 
Nerve
Neurofilament (2F11; Dako)
 
   
 
Histochemical
Alkaline phosphatase
 
                
 
Acid phosphatase
 
        
 
 
-Naphthyl acetate esterase
 
               
 
Oil Red O (lipid accumulation)
20% FBS
 
                   
 
20% Rabbit serum
 
 
 
/
 
    
 
/
 
 
 
/
 
              
 
  
 
, intensive staining; 
 
 
 
, weak staining; 
 
 
 
, negative staining.
*Fisher et al. (1995); provided by Dr. L. Fischer, National Institutes of Dental and Craniofacial Research, National Institutes of Health (Bethesda, MD).
 
‡
 
Zannettino et al. (1996).
 
§
 
Filshie et al. (1998).
 
 
 
Developmental studies hybridoma Bank, University of Iowa, Iowa City, IA.
 
¶
 
Simmons and Torok-Storb (1991).
 
and human) and quite similar to that of marrow stromal
cells derived from each species. However, the human
blood-derived adherent cells were negative for the human
marrow stromal marker, Stro-1, as well as for endoglin and 
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variable proportion of the bone-containing transplants also
demonstrated the formation of a complete hematopoietic
marrow, including adipocytes. Control transplants of mu-
rine and human skin fibroblasts were consistently devoid
of bone, as has been reported previously (Krebsbach et al.,
1997; Kuznetsov et al., 1997; Satomura et al., 2000) (data
not shown). Positive controls using marrow stromal cells
from all species consistently generated an ossicle complete
with bone and hematopoietic marrow and adipocytes, as
has been described (Krebsbach et al., 1997; Kuznetsov et
al., 1997) (data not shown).
The donor origin of tissues formed in the transplants
was documented for guinea pig and human by in situ
hybridization using species-specific DNA-repetitive se-
quences as probes (Fig. 4). This demonstrated that genu-
ine osteoblasts and osteocytes were of donor origin, thus
they originated from clonogenic cells that had been ex-
Muc-18, all of which are expressed in human marrow stro-
mal cells (Gronthos et al., 2000). In addition, blood-
derived cells from all species were negative for alkaline
phosphatase, an enzyme commonly expressed in marrow
stromal cells from mouse, guinea pig, and humans.
To investigate whether the blood-borne adherent cells
had an osteogenic differentiation potential, polyclonal
strains from guinea pig and clonal strains from mouse, rab-
bit, and human cultures were transplanted with a ceramic-
based carrier into the subcutis of immunocompromised
mice (Figs. 1 and 4). Histology-proven bone was demon-
strated in 12–50% of the strains transplanted, depending
on the animal species (Table I and Fig. 4). All transplants
that contained bone were generated by cells that displayed
a fibroblastic morphology in vitro. However, it was not
possible to completely rule out an osteogenic potential for
the polygonal cells due to their overall lower frequency. A
Figure 4. Bone formation by in
vivo transplantation of blood-
derived adherent cells. Strains
of blood-derived adherent cells
from guinea pig (GP, in A, B,
and E), mouse (M, in C), rabbit
(R, in D), and human (H, in F)
were attached to ceramic parti-
cles (c) and transplanted into the
subcutis of immunocompromised
mice. After 8 wk, the transplants
were harvested and sections
were stained with Goldner’s to
distinguish between bone (b,
green in A and B) and osteoid
(open arrow, red in B). In all spe-
cies, bone was deposited on the
surfaces of the ceramic particles
by mature osteoblasts (white ar-
row in B, arrows in C, D, and F).
In transplants in which there
was a significant amount of bone
formed, a fully functional he-
matopoietic marrow (hp) was
also established (A and B), com-
plete with megakaryocytes (ar-
row in B) and adipocytes (a).
Sections of paraffin-embedded
transplants generated by guinea
pig (G) and human (J) blood-
derived adherent cells were used
for in situ hybridization using a
guinea pig–specific sequence (G,
H, and I) and a human-specific
alu sequence (J, K, and L) as
probes. Osteocytes completely
embedded in bone were easily
identifiable in both guinea pig
and human transplants, indicat-
ing the donor nature of the cells
that formed the bone. Specificity
of the probes was demonstrated
by the positive reaction of the guinea pig probe with guinea pig bone (H) and negative reaction with mouse bone (I), and by positive re-
action of the human probe with human bone (K) and negative reaction with mouse bone (L). 
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panded in cultures of blood cells. The hematopoietic tissue
(particularly prominent in transplants generated by guinea
pig cells) was of recipient origin, as expected.
It has been previously documented that osteogenic cells
also form marrow adipocytes upon in vivo transplantation.
Because of the difficulty in visualizing the nuclei of adipo-
cytes, which are rarely intercepted in tissue sections, we
sought to determine the adipogenic potential of the cell
strains in vitro. All strains, including marrow stromal cells,
were negative for PPAR
 
 
 
2, the adipogenic transcription
factor. However, CEBP
 
 
 
 was detected by immunohis-
tochemistry in both human clonal strains, and adipogenesis
was observed in cells from all species upon culture with
rabbit serum, a known inducer of adipogenesis in marrow
stromal osteoprogenitor cells (Fig. 5) (Diascro et al., 1998).
These data show that clonogenic adherent cells of fibro-
blastic growth habit can be isolated in culture from the
adult peripheral blood in a variety of species. A subset of
these cells proved to be osteogenic using the best in vivo as-
say available to date for probing the osteogenic capacity of
putative skeletal stem cells. These cells are also capable of
accumulating lipid, turning into adipocyte-like cells, upon
defined culture conditions in vitro, as do marrow stromal
cells in vitro and in vivo (Bianco et al., 1988; Beresford et
al., 1992). The formation of a hematopoietic marrow in
some transplants in vivo also indicated that a myelosup-
portive reticular stroma was formed. Thus, blood-borne
adherent cells share with marrow stromal stem cells some
critical functional features, such as the ability to generate at
least three phenotypes of the so-called stromal system (os-
teoblasts, adipocytes, and reticular cells).
This is, to the best of our knowledge, the first indication
that cells with true osteogenic potential, directly demon-
strated by the formation of histology-proven bone in vivo,
can circulate. Our data clearly demonstrate that cells with
multiple differentiation potential similar to that of post-
natal marrow stromal stem cells (osteo-adipo-fibrogenic)
can negotiate the circulation. Indication of the ability of
stromal or other extravascular tissue progenitor cells (e.g.,
myogenic) to home to their respective peripheral tissues
when infused into the circulation has recently been pro-
vided (Ferrari et al., 1998; Hou et al., 1999). Our data pro-
vide the complementary notion that stem cells of extravas-
cular mesodermal tissues exist (physiologically) in the
circulating peripheral blood. The origin of these cells, the
mode by which they gain access to the blood stream, and
their physiological role are all issues that remain to be
properly addressed. However, establishment of their exist-
ence provides a significant opportunity for further charac-
terization of their differentiation potential, a novel and
accessible source of progenitor cells of solid-phase meso-
dermal tissues, and an interesting glimpse of a hitherto un-
recognized level of circulation-mediated, systemic integra-
tion of skeletal physiology.
 
The authors acknowledge Prof. J. Spencer, Dr. J. Fredenburgh, Dr. Larry
W. Fisher, and Zimmer, Inc. 
This work was supported by the Telethon Fondazione Onlus (grant
E1029 to P. Bianco).
Submitted: 28 March 2001
Revised: 28 March 2001
Accepted: 19 April 2001
 
References
 
Beresford, J.N., J.H. Bennett, C. Devlin, P.S. Leboy, and M.E. Owen. 1992. Ev-
idence for an inverse relationship between the differentiation of adipocytic
and osteogenic cells in rat marrow stromal cell cultures. 
 
J. Cell Sci.
 
 102:341–
351.
Bianco, P., and G. Cossu. 1999. Uno, nessuno e centomila: searching for the
identity of mesodermal progenitors. 
 
Exp. Cell Res.
 
 251:257–263.
Bianco, P., M. Costantini, L.C. Dearden, and E. Bonucci. 1988. Alkaline phos-
phatase positive precursors of adipocytes in the human bone marrow. 
 
Br. J.
Haematol.
 
 68:401–403.
Bianco, P., and M. Riminucci. 1998. The bone marrow stroma in vivo: ontog-
eny, structure, cellular composition and changes in disease. 
 
In
 
 Marrow Stro-
mal Cell Cultures. J.N. Beresford and M. Owen, editors. Cambridge Univer-
sity Press, Cambridge, UK. 10–25.
Cossu, G., S. Tajbakhsh, and M. Buckingham. 1996. How is myogenesis initi-
ated in the embryo? 
 
Trends Genet.
 
 12:218–223.
Diascro, D.D., R.L. Vogel, T.E. Johnson, K.M. Witherup, S.M. Pitzenberger,
S.J. Rutledge, D.J. Prescott, G.A. Rodan, and A. Schmidt. 1998. High fatty
acid content in rabbit serum is responsible for the differentiation of osteo-
blasts into adipocyte-like cells. 
 
J. Bone Miner. Res.
 
 13:96–106.
Ferrari, G., G. Cusella-De Angelis, M. Coletta, E. Paolucci, A. Stornaiuolo, G.
Cossu, and F. Mavilio. 1998. Muscle regeneration by bone marrow-derived
myogenic progenitors. 
 
Science.
 
 279:1528–1530.
Filshie, R.J., A.C. Zannettino, V. Makrynikola, S. Gronthos, A.J. Henniker,
L.J. Bendall, D.J. Gottlieb, P.J. Simmons, and K.F. Bradstock. 1998.
MUC18, a member of the immunoglobulin superfamily, is expressed on
bone marrow fibroblasts and a subset of hematological malignancies. 
 
Leuke-
Figure 5. Adipocytic conversion of human blood-derived adher-
ent cells in vitro. Immunohistochemistry of human blood-derived
adherent cells revealed expression of the adipocytic transcription
factor, CEBP  (A). The ability of blood-derived cells to form ad-
ipocyte-like cells was further investigated by assessing lipid accu-
mulation as demonstrated by Oil Red O staining after culture
with rabbit serum. As has been seen in marrow stromal cells and
in most blood-derived cell types, small lipid-containing structures
are present in cultures grown in 20% FBS (B). In cultures grown
in 20% rabbit serum, there is a dramatic increase in the number
and size of lipid vacuoles (C), which begin to coalesce in vitro (D). 
Kuznetsov et al.
 
 
 
Circulating Skeletal Stem Cells
 
1139
 
mia. 
 
12:414–421.
Fisher, L.W., J.T. Stubbs III, and M.F. Young. 1995. Antisera and cDNA
probes to human and certain animal model bone matrix noncollagenous pro-
teins. 
 
Acta Orthop. Scand.
 
 266:61–65.
Friedenstein, A.J., K.V. Petrakova, A.I. Kurolesova, and G.P. Frolova. 1968.
Heterotopic transplants of bone marrow. Analysis of precursor cells for os-
teogenic and hematopoietic tissues. 
 
Transplantation.
 
 6:230–247.
Friedenstein, A.J., I.I. Piatetzky-Shapiro, and K.V. Petrakova. 1966. Osteogen-
esis in transplants of bone marrow cells. 
 
J. Embryol. Exp. Morphol.
 
 16:381–
390.
Gronthos, S., M. Mankani, J. Brahim, P.G. Robey, and S. Shi. 2000. Postnatal
human dental pulp stem cells (DPSCs) in vitro and in vivo. 
 
Proc. Natl. Acad.
Sci .USA.
 
 97:13625–13630.
Hou, Z., Q. Nguyen, B. Frenkel, S.K. Nilsson, M. Milne, A.J. van Wijnen, J.L.
Stein, P. Quesenberry, J.B. Lian, and G.S. Stein. 1999. Osteoblast-specific
gene expression after transplantation of marrow cells: implications for skele-
tal gene therapy. 
 
Proc. Natl. Acad. Sci. USA.
 
 96:7294–7299.
Krebsbach, P.H., S.A. Kuznetsov, K. Satomura, R.V. Emmons, D.W. Rowe,
and P.G. Robey. 1997. Bone formation in vivo: comparison of osteogenesis
by transplanted mouse and human marrow stromal fibroblasts. 
 
Transplanta-
tion.
 
 63:1059–1069.
Kuznetsov, S., and P. Gehron Robey. 1996. Species differences in growth re-
quirements for bone marrow stromal fibroblast colony formation in vitro.
 
Calcif. Tissue Int.
 
 59:265–270.
Kuznetsov, S.A., P.H. Krebsbach, K. Satomura, J. Kerr, M. Riminucci, D.
Benayahu, and P.G. Robey. 1997. Single-colony derived strains of human
marrow stromal fibroblasts form bone after transplantation in vivo. 
 
J. Bone
Miner. Res.
 
 12:1335–1347.
Owen, M. 1988. Marrow stromal stem cells. 
 
J. Cell Sci.
 
 10:63–76.
Satomura, K., P. Krebsbach, P. Bianco, and P. Ghernon Robey. 2000. Osteo-
genic imprinting upstream of marrow stromal cell differentiation. 
 
J. Cell
Biochem.
 
 78:391–403.
Simmons, P.J., and B. Torok-Storb. 1991. Identification of stromal cell precur-
sors in human bone marrow by a novel monoclonal antibody, STRO-1.
 
Blood.
 
 78:55–62.
Zannettino, A.C., J.R. Rayner, L.K. Ashman, T.J. Gonda, and P.J. Simmons.
1996. A powerful new technique for isolating genes encoding cell surface an-
tigens using retroviral expression cloning. 
 
J. Immunol.
 
 156:611–620.